<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="at: [[inbox]]
Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360 Caring for patients with chronic non–cancer-related pain remains challenging."><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-mlkgi530p-htlin222.vercel.app/api/blog?templateTitle=Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360"><title>Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=alternate type=application/rss+xml href=https://www.physician.tw//feed.xml title><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.720e2c4835986a3891d6eef3a55faa22.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.440c12afe56c47722e71383f56d9f8f0.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.9d824aa930866f2c31941e3db882301d.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=搜尋 placeholder="請輸入像是：hypertension 之類的來看沒有沒什麼有趣的🎳"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>蜥蜴花園🦎🌱🪴🌲</a></h1><div class=spacer></div><div id=search-icon><p>搜尋</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">搜尋圖示</title><desc id="desc">打開搜尋圖標</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>明亮模式</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>黑暗模式</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360</h1><p class=meta>最後更新於
Feb 23, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/Ambulatory%20Care%20-%20Chronic%20Pain%20and%20Opioids%20-%20Fast%20Facts%20%20NEJM%20Resident%20360.md rel=noopener>🪚 編輯原始文件</a></p><ul class=tags></ul><p>at: <a href=/inbox rel=noopener class=internal-link data-src=/inbox>inbox</a></p><a href=#ambulatory-care---chronic-pain-and-opioids---fast-facts--nejm-resident-360><h1 id=ambulatory-care---chronic-pain-and-opioids---fast-facts--nejm-resident-360><span class=hanchor arialabel=Anchor># </span>Ambulatory Care - Chronic Pain and Opioids - Fast Facts | NEJM Resident 360</h1></a><p>Caring for patients with chronic non–cancer-related pain remains challenging. In many areas of the United States, increased rates of opioid misuse and overdose have led to restrictions on prescribing opioids. Health care providers (including residents) need to understand and utilize evidence-based treatments for patients with chronic pain, reducing opioid prescriptions where possible while ensuring safer prescribing when indicated.</p><ul><li><p>Key Principles for Assessing Chronic Pain</p></li><li><p>Key Principles for Managing Chronic Pain</p></li><li><p>Opioid Therapy</p></li><li><p>Fibromyalgia</p></li></ul><p>In 2016, the Centers for Disease Control and Prevention (CDC) released an important guideline for prescribing opioids for chronic noncancer and nonpalliative pain.</p><a href=#key-principles-for-assessing-chronic-pain><h3 id=key-principles-for-assessing-chronic-pain><span class=hanchor arialabel=Anchor># </span>Key Principles for Assessing Chronic Pain</h3></a><ul><li><p>Begin with a thorough physical examination and history. Key portions of the history include: previous therapies; exacerbating and alleviating features; duration and severity; location; mechanism of any previous injuries; and presence of alarm features, including but not limited to neurologic deficits, fevers, and weight loss.</p></li><li><p>Review the patient’s functional status, including activities of daily living and instrumental activities of daily living.</p></li><li><p>Screen for comorbid mood disorders and substance use disorders.</p></li></ul><a href=#key-principles-for-managing-chronic-pain><h3 id=key-principles-for-managing-chronic-pain><span class=hanchor arialabel=Anchor># </span>Key Principles for Managing Chronic Pain</h3></a><ul><li><p>A multimodal treatment strategy is the foundation of chronic pain management. Nonpharmacologic therapy (physical therapy, exercise therapy, weight loss, and cognitive behavioral techniques), nonopioid pharmacologic therapy (acetaminophen, nonsteroidal anti-inflammatory drugs [NSAIDs], certain antidepressants, and anticonvulsants), and interventional approaches (injections) are preferred first-line options for chronic pain.</p></li><li><p>Consider a trial of opioids if the benefits of treating a patient’s pain and function are anticipated to outweigh the risks.</p></li><li><p>When prescribing opioids:</p></li><li><ul><li><p>Where appropriate, combine with nonpharmacologic therapy and nonopioid pharmacologic therapy.</p></li><li><p>Start with immediate-release opioids at the lowest effective dosage (“start low, go slow”).</p></li><li><p>Avoid prescribing opioids with concomitant benzodiazepines.</p></li><li><p>Establish treatment goals, including realistic goals for what pain control can be achieved and an anticipated timeline for weaning opioids, in a structured patient–provider agreement.</p></li><li><p>Schedule frequent face-to-face visits to assess the risks and benefits of therapy, do random urine drug testing and pill counts to evaluate for misuse or diversion, and use a structured assessment of adverse effects and functional improvements at each visit.</p></li><li><p>Review state prescription-drug–monitoring programs.</p></li><li><p>Consider offering naloxone to those at increased risk for overdose.</p></li><li><p>Ensure the patient is placed on a bowel regimen and monitored for opioid-induced constipation.</p></li></ul></li></ul><a href=#opioid-therapy><h3 id=opioid-therapy><span class=hanchor arialabel=Anchor># </span>Opioid Therapy</h3></a><p>Opioids are not first-line therapy for chronic non–cancer-related pain because of their potential risks, lack of evidence of long-term efficacy, and the possibility of tolerance or hyperalgesia. However, opioids may be appropriate on a trial basis for patients with chronic pain if the following conditions are met:</p><ul><li><p>The pain is severe and has a significant effect on function and quality of life.</p></li><li><p>The pain has not responded favorably to other appropriate interventions, or the other available interventions represent higher risk (e.g., NSAIDs in a patient with chronic kidney disease).</p></li><li><p>The benefits of opioid therapy are expected to outweigh the risks.</p></li></ul><p>Opioids are a mainstay for severe cancer pain, where they can help achieve pain control in 70% to 90% of patients. They are also beneficial for symptom control in palliative and end-of-life care.</p><p><strong>When initiating opioid therapy consider the following steps:</strong></p><ol><li><p>Determine whether there is an indication for opioid therapy</p></li><li><p>Establish clear functional goals with the patient. Goals should be SMART:</p></li></ol><ul><li><p><strong>S</strong>pecific about what the patient will set out to do</p></li><li><p><strong>M</strong>easurable, so that you and the patient can determine whether the goal has been met</p></li><li><p><strong>A</strong>ction-oriented (rather than passive)</p></li><li><p><strong>R</strong>ealistic with respect to the patient’s current condition</p></li><li><p><strong>T</strong>ime-bound, so that the goal is being measured within a very specific time frame</p></li></ul><ol start=3><li><p>Plan to continue nonopioid medications for complementary and synergistic effects as helpful</p></li><li><p>Assess the potential risks of opioid therapy, including:</p></li></ol><ul><li><p>risk of misuse</p></li><li><p>medical risks, such as sleep apnea, obesity hypoventilation syndrome, renal or hepatic dysfunction, or use of other central nervous system (CNS) depressants</p></li></ul><ol start=5><li><p>Consider referral to an appropriate specialist if you identify a high risk of misuse or a need for interventional pain management</p></li><li><p>Institute a patient–provider agreement. Such agreements typically outline the following:</p></li></ol><ul><li><p>The planned frequency of follow-up visits to assess pain, function, adverse effects, and progress toward established goals; follow-up is typically at least every 4 weeks initially, progressing to at least every 3 months</p></li><li><p>Review of all medications in the planned regimen, including name, dose, frequency, and instructions for taking the medication</p></li><li><p>Review of risky medication-associated behaviors, such as requesting early refills or obtaining refills for controlled substances from other providers</p></li><li><p>Tools to be used for risk monitoring, such as urine drug testing, pill counts, and reports from the prescription drug monitoring program (PDMP)</p></li></ul><ol start=7><li><p>Provide an at-home naloxone rescue kit</p></li><li><p>For opioid-naive patients, start with a short-acting agent:</p></li></ol><ul><li><p>in general, initiate these agents at a low dose and keep at the lowest dose possible</p></li><li><p>exercise caution with dosing in patients with risks, incuding obstructive sleep apnea, hepatic or renal dysfunction, or concomitant use of other CNS depressants.</p></li></ul><p>Once a patient has been taking a short-acting opioid for at least one week, he or she may transition to an extended-release/long-acting opioid.</p><p><strong>Drug-drug interactions:</strong> Clinicians should be aware of potential drug-drug interactions prior to initiating opioid therapy. Certain opioids, such as fentanyl, codeine, oxycodone, methadone, and tramadol, are metabolized by the liver’s cytochrome P-450 (CYP450) enzymes. Medications that inhibit the CYP450 pathway have the potential to reduce the clearance of these opioids and lead to dangerous dose accumulation, thus placing the patient at risk for unintentional opioid overdose. Several types of medications should be avoided in the setting of opioid therapy because of potentiating effects on sedation and respiratory depression including:</p><ul><li><p>benzodiazepines</p></li><li><p>sedative hypnotics</p></li><li><p>tricyclic antidepressants</p></li><li><p>monoamine oxidase inhibitors</p></li></ul><p><strong>Monitoring response:</strong> The patient’s response to therapy should be assessed at each follow up appointment. A validated pain assessment scale should be used to assist in response to treatment assessment. One example is the PEG scale, which assesses pain across three dimensions:</p><ul><li><p><strong>P</strong>ain intensity</p></li><li><p><strong>E</strong>njoyment of life</p></li><li><p><strong>G</strong>eneral activity level</p></li></ul><p><strong>Adverse effects:</strong> Patients should be monitored for adverse effects of opioid therapy including:</p><ul><li><p>constipation</p></li><li><p>urinary retention</p></li><li><p>psychomotor Impairment</p></li><li><p>cognitive Impairment</p></li><li><p>itch, nausea and vomiting</p></li></ul><p>If an adverse effect persists, general management approaches include:</p><ul><li><p>reducing the opioid dose</p></li><li><p>switching to an alternative opioid (known as opioid rotation)</p></li><li><p>treating the adverse effect with medication if needed</p></li></ul><p><strong>Rotating opioids:</strong> When patients rotate opioids, they generally take a lower dose and often experience fewer adverse effects with an equivalent analgesic response. In addition, because of unpredictable cross-tolerance, patients may develop sedation and overdose (or pain and withdrawal) on the new opioid. Therefore, caution and careful monitoring are advised.</p><a href=#fibromyalgia><h3 id=fibromyalgia><span class=hanchor arialabel=Anchor># </span>Fibromyalgia</h3></a><p>Fibromyalgia is a well-defined chronic pain syndrome with a prevalence of 2% to 4%. It is characterized by widespread musculoskeletal pain for at least 3 months in the absence of any inflammatory or metabolic cause and remains a clinical diagnosis of exclusion. It also often involves some combination of chronic fatigue, sleep disturbances, cognitive difficulties, depressed mood, anxiety, headaches, and digestive problems, such as irritable bowel syndrome.</p><p>The American College of Rheumatology (ACR) established diagnostic criteria in 1990 and 2010, with a slight revision in 2016 to include a generalized pain criterion.</p><ul><li><p>1990 ACR diagnostic criteria: at least 11 out of 18 positive tender points</p></li><li><p>2016 ACR diagnostic criteria: a widespread pain index ≥7 and a symptom severity scale score ≥5 or a widespread pain index 3–6 and a symptom severity scale score ≥9; patients must have pain symptoms in ≥4 of 5 regions.</p></li></ul><p>Treatment of fibromyalgia involves both pharmacologic and nonpharmacologic therapy (e.g., graded exercise, meditation, and cognitive behavioral techniques). The three FDA-approved medications for fibromyalgia are duloxetine, milnacipran, and pregabalin. Gabapentin and tricyclic antidepressants are also frequently used. Opioids are not recommended.</p><p><a href=/inbox rel=noopener class=internal-link data-src=/inbox>inbox</a></p></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>↩️ 反向連結</h3><ul class=backlinks><li><a href=/OPD/ data-ctx="Ambulatory Care - Chronic Pain and Opioids - Fast Facts  NEJM Resident 360" data-src=/OPD class=internal-link>ambulatory</a></li><li><a href=/OPD-2/ data-ctx="Ambulatory Care - Chronic Pain and Opioids - Fast Facts  NEJM Resident 360" data-src=/OPD-2 class=internal-link>ambulatory</a></li><li><a href=/all-list-of-resident360/ data-ctx="Ambulatory Care - Chronic Pain and Opioids - Fast Facts  NEJM Resident 360" data-src=/all-list-of-resident360 class=internal-link>all list of resident360</a></li><li><a href=/ambulatory/ data-ctx="Ambulatory Care - Chronic Pain and Opioids - Fast Facts  NEJM Resident 360" data-src=/ambulatory class=internal-link>ambulatory</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>🤯互動圖</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div><div id=contact_buttons><footer><p>本網站是由 Hsieh-Ting Lin 以❤️ 用 <a href=https://github.com/jackyzha0/quartz>Quartz</a>這個酷東西種出來🪴 , © 2023</p><p><a href=https://www.buymeacoffee.com/htl.lizard><img src=https://cdn.buymeacoffee.com/buttons/v2/default-yellow.png width=200></a></p><ul><li><a href=https://www.physician.tw/>🏠首頁</a></li><li><a href=https://www.facebook.com/Tim.H.Lin>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://medium.com/@hsieh-ting-lin>Medium</a></li></ul></footer></div></div></body></html>